Status:
TERMINATED
Protection of Rectum From High Radiation Doses Using a Spacer
Lead Sponsor:
University of Oulu
Collaborating Sponsors:
Oulu University Hospital
Conditions:
Prostatic Neoplasms
Genital Neoplasms, Male
Eligibility:
MALE
50-78 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the usefulness of diluted and non-diluted DuraSeal product as a spacer between prostate and rectum in prostate cancer low-dose brachytherapy.
Detailed Description
Radiation therapy for prostate cancer leads to inappropriate radiation dose to the rectum wall leading rectum adverse effects in long term for some patients. A resorbable spaces between prostate and r...
Eligibility Criteria
Inclusion
- prostate cancer patients with planned low-dose brachytherapy for the treatment of prostate cancer
Exclusion
- not willing to participate this study
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2017
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT01918605
Start Date
June 1 2013
End Date
October 1 2017
Last Update
October 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oulu University Hospital
Oulu, Finland, 90029